Author:
Keefe Dorothy,Lees Jude,Horvath Noemi
Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, Shea T, Yanovich S, Hansen K, Noga S, McCarty J, LeMaistre CF, Sung EC, Blazar BR, Elhardt D, Chen MG, Emmanouilides C (2005) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351(25):2590–2598
2. Aaronson SA et al (1991) Keratinocyte growth factor: a fibroblast growth factor family member with unusual target cell specificity. Ann N Y Acad Sci 638:62–77
3. Sonis ST et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(Suppl 9):1995–2025
4. Clarke SJ, Abdi E, Davis D (2001) Recombinant human keratinocyte growth factor (rHuKGF) prevents chemotherapy-induced mucositis in patients with advanced colorectal cancer: a randomized phase II trial. Proceedings of ASCO 20:383a (abstract)
5. Farrell CL et al (1998) Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 58(5):933–939
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献